Your browser doesn't support javascript.
loading
Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.
Kumar, Rajesh; Deshpande, Suprit; Sewall, Leigh M; Ozorowski, Gabriel; Cottrell, Christopher A; Lee, Wen-Hsin; Holden, Lauren G; Richey, Sara T; Chandrawacar, Antra Singh; Dhiman, Kanika; Kumar, Vivek; Ahmed, Shubbir; Hingankar, Nitin; Kumar, Naresh; Murugavel, Kailapuri G; Srikrishnan, Aylur K; Sok, Devin; Ward, Andrew B; Bhattacharya, Jayanta.
Afiliación
  • Kumar R; Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, India.
  • Deshpande S; Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, India.
  • Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Ozorowski G; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Cottrell CA; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Holden LG; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Richey ST; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Chandrawacar AS; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Dhiman K; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Ashish; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Kumar V; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Ahmed S; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Hingankar N; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Kumar N; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Murugavel KG; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Srikrishnan AK; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Sok D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
  • Ward AB; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.
  • Bhattacharya J; IAVI Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, California, United States of America.
PLoS Pathog ; 17(4): e1008977, 2021 04.
Article en En | MEDLINE | ID: mdl-33826683
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / VIH-1 / Anticuerpos Neutralizantes / Antígenos Virales Límite: Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article País de afiliación: India
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / VIH-1 / Anticuerpos Neutralizantes / Antígenos Virales Límite: Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article País de afiliación: India